- The Dispatch @ DiscussPharma
- Posts
- The Pharma Dispatch 💊 - Issue #85
The Pharma Dispatch 💊 - Issue #85
Why China’s traditional medicine boom is dangerous, radiologists see their jobs at risk, could Zika be used to treat brain tumors? and other interesting reads from this week.
General
AstraZeneca, Amgen severe asthma drug shines. Link
FDA shuts down CAR-T clinical trials. Link
A revival of traditional Chinese medicine. Link
Why China’s traditional medicine boom is dangerous. Link
This controversial biotech may yet defy its skeptics. Link
Facebook's ad sales team is hitting up the drug industry. Link
What lies ahead for new Novartis CEO Vasant Narasimhan. Link
Departing Novartis CEO sets his eyes on Silicon Valley. Link
Digital Health
This startup is bringing augmented reality to dentistry. Link
Scanning the future, radiologists see their jobs at risk. Link
Meditation money: mindfulness start-ups scale up. Link
Amazing technologies changing the future of dermatology. Link
Research
Could Zika be used to treat brain tumors? Link
Assumptions of how antibiotics work may be incorrect. Link
Visualising genomic data, inspired by Google Maps. Link
Perspective and Opinions
Understanding and predicting cancer metastasis: soil and seed. Link
How complex drugs keep generics at bay. Link
Skin lightening: the dangerous obsession that’s worth billions. Link
Interesting
Helping coma patients communicate. Link
‘Biological teleporter’ to fight pandemics. Link
Startups of the Week
Notable Labs is developing a personalized treatment service for people with cancer that prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor.
Excision BioTherapeutics focuses on the development and commercialization of advanced gene editing therapeutics for the treatment and eradication of life-threatening disease caused by neurotropic viruses (viral infections).
Amal Therapeutics uses KISIMA, its proprietary vaccine technology platform to develop and progress therapeutic vaccines in oncology.
Antidote uses cutting-edge technology to match the right patients with the right trials, helping medical researchers make faster progress, and offering new treatment options to patients in need.